High efficient production of Pr55gag virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A

被引:71
作者
Buonaguro, L
Buonaguro, FM
Tornesello, ML
Mantas, D
Beth-Giraldo, E
Wagner, R
Michelson, S
Prevost, MC
Wolf, H
Giraldo, G [1 ]
机构
[1] Ist Nazl Tumori Fond G Pascale, Div Viral Oncol, Naples, Italy
[2] Ist Nazl Tumori Fond G Pascale, AIDS Reference Ctr, Naples, Italy
[3] Univ Regensburg, Inst Med Microbiol, D-8400 Regensburg, Germany
[4] Inst Pasteur, Dept Retrovirus, Unite Immunol Virale, Paris, France
关键词
vaccine; HIV-1; clade-A; VLPs; baculovirus;
D O I
10.1016/S0166-3542(00)00136-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main goal of this study was to investigate a novel approach for an efficient and reproducible production of Virus-Like Particles (VLPs) expressing multiple HIV-1 epitopes. The HIV-1 Pr55(gag)-based VLPs have been produced in a Baculovirus expression system, using a transfer vector able to support the independent expression of different open reading frames (ORFs). In this regard, the gp120 derived from 94UG018 HIV-1(A) isolate, previously studied in our laboratory, has been packaged into the VLPs together with nef and pol ORFs. In particular. the gp120(UG) sequence shows a 90% homology in the V3 region competed to African HIV-1 strains of the A-clade. This novel approach is extremely effective for the production of VLPs expressing all the epitopes, as confirmed by Western Blot characterization. Furthermore, the resulting HIV-VLP(A)s show the expected density(1.14-1.18 g/ml on a 10-60% sucrose gradient and the morphology of an immature virion at standard transmission electron microscopy. Our results demonstrate that this strategy is highly efficient for expressing a balanced amount of multiple epitopes and their packaging in VLP structures, without affecting the Pr55(gag) autoassembling capacities. Furthermore, the genetic transposition performed in a modified E. coli represents a methodological improvement. allowing a faster and more reproducible identification of recombinant Baculovirus DNA molecules. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:35 / 47
页数:13
相关论文
共 50 条
  • [1] UGANDAN HIV-1 V3 LOOP SEQUENCES CLOSELY RELATED TO THE UNITED-STATES EUROPEAN CONSENSUS
    ALBERT, J
    FRANZEN, L
    JANSSON, M
    SCARLATTI, G
    KATAAHA, PK
    KATABIRA, E
    MUBIRO, F
    RYDAKER, M
    ROSSI, P
    PETTERSSON, U
    WIGZELL, H
    [J]. VIROLOGY, 1992, 190 (02) : 674 - 681
  • [2] PROTECTION BY ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS IN MACAQUES AGAINST CHALLENGE WITH VIRUS-INFECTED CELLS
    ALMOND, N
    KENT, K
    CRANAGE, M
    RUD, E
    CLARKE, B
    STOTT, EJ
    [J]. LANCET, 1995, 345 (8961): : 1342 - 1344
  • [3] Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus
    Berglund, P
    QuesadaRolander, M
    Putkonen, P
    Biberfeld, G
    Thorstensson, R
    Liljestrom, P
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (17) : 1487 - 1495
  • [4] PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160
    BERMAN, PW
    GREGORY, TJ
    RIDDLE, L
    NAKAMURA, GR
    CHAMPE, MA
    PORTER, JP
    WURM, FM
    HERSHBERG, RD
    COBB, EK
    EICHBERG, JW
    [J]. NATURE, 1990, 345 (6276) : 622 - 625
  • [5] Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
    Boyer, JD
    Ugen, KE
    Wang, B
    Agadjanyan, M
    Gilbert, L
    Bagarazzi, ML
    Chattergoon, M
    Frost, P
    Javadian, A
    Williams, WV
    Refaeli, Y
    Ciccarelli, RB
    McCallus, D
    Coney, L
    Weiner, DB
    [J]. NATURE MEDICINE, 1997, 3 (05) : 526 - 532
  • [6] Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda
    Brennan, CA
    Lund, JK
    Golden, A
    Yamaguchi, J
    Vallari, AS
    Phillips, JF
    Kataaha, PK
    Jackson, JB
    Devare, SG
    [J]. AIDS, 1997, 11 (15) : 1823 - 1832
  • [7] PRESENCE OF MULTIPLE GENETIC SUBTYPES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRUSES IN UGANDA
    BRUCE, C
    CLEGG, C
    FEATHERSTONE, A
    SMITH, J
    BIRYAHAWAHO, B
    DOWNING, R
    ORAM, J
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) : 1543 - 1550
  • [8] HETERODUPLEX MOBILITY ASSAY AND PHYLOGENETIC ANALYSIS OF V3 REGION SEQUENCES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES FROM GULU, NORTHERN UGANDA
    BUONAGURO, L
    DELGAUDIO, E
    MONACO, M
    GRECO, D
    CORTI, P
    BETHGIRALDO, E
    BUONAGURO, FM
    GIRALDO, G
    TAMBURINI, M
    CASTELLO, G
    DECLICH, S
    LUKWIYA, M
    SEMPALA, S
    BIRYAMWAHO, B
    DOWNING, R
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (12) : 7971 - 7981
  • [9] Sequence note - A novel glycoprotein 120 sequence from an HIV type 1 isolate of the A clade identified in North Uganda
    Buonaguro, L
    Buonaguro, FM
    Russo, F
    Tornesello, ML
    Beth-Giraldo, E
    Wagner, R
    Wolf, H
    Giraldo, G
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (14) : 1287 - 1289
  • [10] BUONAGURO L, 1992, J VIROL, V66, P7156